Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: Incidence and risk factors

Table 2 Biochemical characteristics of male and female primary biliary cirrhosis patients at hepatocellular carcinoma diagnosis

Variable	Total	Men	Women	P value1
	(n= 52)	(n= 16)	(n= 36)
Alanine transaminase (U/L)	43.04 ± 42.28	64.25 ± 55.48	33.61 ± 31.45	0.012
Aspartate aminotransferase (U/L)	77.83 ± 56.24	111.38 ± 72.47	62.92 ± 40.19	0.005
Alkaline phosphatase (U/L)	229.29 ± 190.44	308.81 ± 209.37	193.94 ± 172.87	0.015
γ-glutamyl transpeptidase (U/L)	156.90 ± 179.05	253.13 ± 220.54	114.14 ± 140.55	0.010
Albumin (g/L)	28.42 ± 5.67	28.06 ± 5.64	28.58 ± 5.75	0.720
Total bilirubin (μmol/dL)	61.19 ± 102.13	74.14 ± 64.25	55.43 ± 115.41	0.071
α-fetoprotein elevating, n (%)	34 (65.38)	9 (56.25)	25 (69.44)	0.356
Prothrombin time (s)	13.49 ± 2.20	12.79 ± 1.91	13.8 ± 2.28	0.159
International standardization ratio	1.15 ± 0.23	1.13 ± 0.14	1.17 ± 0.26	0.410
White blood cells (109/L)	4.29 ± 2.35	5.13 ± 2.32	3.92 ± 2.30	0.073
Red blood cells (1012/L)	3.31 ± 0.66	3.56 ± 0.76	3.19 ± 0.60	0.096
Platelets (109/L)	76.57 ± 40.50	85.20 ± 48.26	72.74 ± 36.64	0.506

¹Men compared with women. Data expressed as mean ± SD or n (%) of patients.